Roche Lightmix Digital Oncology Assays

Roche has launched five research-use-only digital PCR assays for use with the firm's Digital LightCycler System. The Lightmix Digital Assays detect the BRAF V600E, EGFR T790M, EGFR Ex19del, KRAS G12D, and PIK3CA E545K mutations. The assays are being brought to market by TIB MolBiol, a subsidiary Roche acquired in 2021.